Efficacy and Safety of Direct Oral Anticoagulants in Elderly Patients With Atrial Fibrillation: A Network Meta-Analysis

Background: Direct oral anticoagulants (DOACs) have been widely used in patients with atrial fibrillation (AF) for antithrombotic prophylaxis, which were shown to have a favorable risk–benefit profile. However, there are no guidelines for the use of DOACs in elderly patients (aged ≥75 years) with AF...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Kaisheng, Cheng, Jinqun, Rao, Shufang, Xu, Huafu, Li, Lixia, Gao, Yanhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154089/
https://www.ncbi.nlm.nih.gov/pubmed/32318577
http://dx.doi.org/10.3389/fmed.2020.00107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154089/
https://www.ncbi.nlm.nih.gov/pubmed/32318577
http://dx.doi.org/10.3389/fmed.2020.00107

Ejemplares similares